Omeros (OMER) Gross Profit Growth (1y) (2015 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,488.21% |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 15.39% |
| Jun 30, 2021 | 112.81% |
| Mar 31, 2021 | -10.62% |
| Dec 31, 2020 | -68.06% |
| Sep 30, 2020 | -13.07% |
| Jun 30, 2020 | -49.87% |
| Mar 31, 2020 | 7.49% |
| Dec 31, 2019 | 51.03% |
| Sep 30, 2019 | 546.94% |
| Jun 30, 2019 | 1,634.76% |
| Mar 31, 2019 | 1,463.03% |
| Dec 31, 2018 | 64.42% |
| Sep 30, 2018 | -78.71% |
| Jun 30, 2018 | -90.94% |
| Mar 31, 2018 | -88.44% |
| Dec 31, 2017 | 6.15% |
| Sep 30, 2017 | 96.81% |
| Jun 30, 2017 | 75.61% |
| Mar 31, 2017 | 69.01% |
| Dec 31, 2016 | 100.14% |
| Sep 30, 2016 | 262.37% |
| Jun 30, 2016 | 242.91% |
| Mar 31, 2016 | 1,781.17% |
| Dec 31, 2015 | 3,376.67% |
| Sep 30, 2015 | 1,307.01% |
| Jun 30, 2015 | 6,171.11% |
| Mar 31, 2015 | 277.00% |